C-JQ3FX-Therma
biopreservation, cryopreservation, antifreeze molecules
research tools
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-JQ3F
C-JQ3FC-JQ3Fbiopreservation, cryopreservation, antifreeze molecules
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Exhibitors Skip to main content Toggle navigation Home Exhibitors Home Exhibitors Exhibitors Type here to filter the list All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # Sort by Booth Sort by Company A Favorite 210 All Call Nursing Favorite 114 Amber Specialty Pharmacy Favorite 407 American Foundation for Donation & Transplantation B Favorite 122 Bridge to Life Ltd. Favorite 310 Buckeye Transplant Services C Favorite 989 Cadmium Test Favorite 999 Cadmium Test Company Favorite 102 CareDx, Inc. Favorite 423 Children's Organ Transplant Association Favorite 207 CompuMed, Inc. D Favorite
Partners - ISCT 2026 Dublin ISCT | Connecting Science to Medicine Skip to main content (Press Enter). Login Skip auxiliary navigation (Press Enter). ISCT Journal Media Contact Us Subscribe to ISCT 2027 Skip main navigation (Press Enter). Toggle navigation Home Accreditation Program Program at a Glance Translational Pathway Program Roundtable Program Lab Practices Essentials Track Program Schedule Corporate Program Speaker Line Up Keynote Speaker Training Events Thought Leadership Events Networking Events Gala 5K Run Abstracts Submission Information Presenter Information Abstract A … cells to create breakthrough innovations. Corning supports research for several application areas including core cell culture, bioprocess, cancer research, primary and stem cells, drug screening, cell and gene therapy, disease modeling, lab automation and more. Learn more at www.corning.com/lifesciences. Visit Website As a global health care company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of pa … o acids and a longtime collaborator with CiRA (Center for iPS Cell Research and Application), we contribute proprietary technologies and know-how in culture medium design, composition, and quality control. We believe that providing animal origin–free, high-performance media is essential to unlocking the full potential of human pluripotent stem cell science. Guided by our corporate message “Eat Well, Live Well.,” Ajinomoto is less focused on what has been done and more on what … of results and pride in the insights our customers achieve. More than 35 Nobel Prize winners among more than 500,000 customers worldwide are proof of that success. We will continue to define the advancements of tomorrow – in line with our vision of making improvements in life possible. Visit Website Uniphar is a trusted global partner to pharma, medtech and biotech, delivering solutions that connect medicines and technologies with patients worldwide. With over 57 years of ex … ell as storage and transport of liquid helium and nitrogen. Additional areas of application include the transfer of liquefied gases such as LHe, LIN, LAR, LOX and LH2, truck transport tanks with capacity of up to 3,000 liters, cryogenic systems for transport cooling, and advanced control and monitoring technology for cryogenic processes. Cryother
Blackstone to Acquire Therma Holdings LLC, a Leading Provider of Mechanical, Electrical and Energy Efficiency Services - Blackstone Skip to main content Blackstone Expand Navigation The Firm The Firm Overview Our People Our Impact Careers Our Clients Institutional Investors Financial Advisors Family Offices Insurers Defined Contribution What We Do Businesses Private Equity Real Estate Credit & Insurance Blackstone Multi-Asset Investing Strategic Partners Tactical Opportunities Infrastructure Life Sciences Growth Energy Transition Partners Transformation Technology & Innovations Black … Products Blackstone Real Estate Income Trust (BREIT) Blackstone Private Credit Fund (BCRED) Blackstone Private Multi-Asset Credit and Income Fund (BMACX) View All News & Insights News View All Press Releases In the News Insights View All Market Views Pattern Recognition Essentials of Private Markets Overview Private Equity Private Credit Private Real Estate Private Infrastructure Financial Advisors Private Wealth at Blackstone Overview Blackstone University Overview Ess … Products Blackstone Real Estate Income Trust (BREIT) Blackstone Private Credit Fund (BCRED) Blackstone Private Multi-Asset Credit and Income Fund (BMACX) View All Shareholders LP Login Blackstone to Acquire Therma Holdings LLC, a Leading Provider of Mechanical, Electrical and Energy Efficiency Services November 09, 2020 November 09, 2020 NEW YORK & SAN JOSE Today, Blackstone (NYSE: BX) announced that private equity funds managed by Blackstone Energy Partners have entered … ction, and energy management services. RE Tech designs, administers, and tracks award-winning energy efficiency and environmental, social and governance (ESG) programs for clients – which include leading real estate investors, owners, and governments. In total, their 45+ professionals have delivered more than $200 million of utility cost reductions by implementing approximately 10,000 energy efficiency measures across 3,000+ assets. RE Tech has been working with Blackstone on … By selecting the relevant option, you certify that it accurately reflects your residency. I am not a United States Resident I am a United States Resident Footnote Title Footnote Title Footnote Title Footnote Title Footnote Title Footnote Title Footnote Title Footnote Title Footnote Title Footnote Title Footnote Title “Institutional quality” refe
Virtual Press Office: Trade show news, exhibitor news, online press kits --> Send a News Release --> Blog For Journalists News Solutions Resources --> --> Overview Marketing Public Relations IR & Compliance Agency All Products Contact Us Journalists Blog Become a Member Send a Release --> Order a Press Kit News Solutions Resources --> Search Contact Us +1 973-783-7787 option 0 Home Products Event Organizer Services News Releases Events Press Services Overview Marketing Public Relations IR & Compliance Agency All Products --> News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29
X-Therma Welcomes Biotech Veteran Neil Warma to its Board of Directors - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News X-Therma Welcomes Biotech Veteran Neil Warma to its Board of Directors June 10, 2025 Isaac Arruda X-Therma announced the appointment of Neil Warma, a seasoned healthcare entrepreneur with over 25 years of experience in managing and advising numerous biotechnology and pharmaceutical companies globally, to its Board of Directors. Source: PR Newswire HERCULES, … the Lawrence Berkeley National Laboratory and received over $11M contracts and grant support from the U.S. Department of Defense, the National Science Foundation, and the California Institute for Regenerative Medicine. The company recently closed an oversubscribed Series A of $13M. More News X-Therma Showcases Groundbreaking Organ Preservation Technology at Johns Hopkins’ “Hopkins on the Hill” Event Read More X-Therma Welcomes Biotech Veteran Neil Warma to
ADVANCING CELL AND GENE THERAPIES | Advanced Therapies USA Toggle navigation Advanced Therapies USA 2026 4 - 5 November Hynes Convention Center, Boston home our story agenda conference 2026 partners Clinician Hub Poster Application CPD Accreditation sponsors & exhibitors Sponsor/Exhibit Start-Up Application Download Prospectus Attendee Breakdown Speakers Apply to Speak register- offer ends july 24 contact us Accommodation FAQ November 4-5 2026 Hynes Convention Center, Boston USA ADVANCING CELL AND GENE THERAPIES Sponsor or exhibit Tickets from $445 Register now THE FUTURE OF ADVANCED THERA … phia. His team leads technology innovation efforts in payload designs for AAVs, application of next generation sequencing and bioinformatics approaches to developing... Close Full biography × Miguel Forte, CEO, Kiji Therapeutics and President, International Society of Cell and Gene Therapy, Kiji Therapeutics Immediate Past President and Board of Directors member of the International Society of Cell and Gene Therapy (ISCT) from June 2026. Previously President ISCT 2024 t … tor Exhibitor Startup Plus Startup Plus Startup Startup Startup Startup Startup Apply to Sponsor/Exhibit What is the Advanced Therapies Congress? Conference The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development with 8 tracks of content over 2 days. SEE LATEST SPEAKERS Exhibition 50 leading solution providers to meet your needs across all stages of cell and gene therapy development DOWNLOAD PROSPECTUS Networki
Instagram Instagram Log In Sign Up Close Never miss a post from coldchainplatform Sign up for Instagram to stay in the loop. Sign up Log in coldchainplatform • Follow More options coldchainplatform 1w X-Therma Inc. has announced the commercial launch of its XT-NoVo® and TimeSeal® platform, designed to support ice-free, DMSO-free, sub-zero preservation and transport of high-value biologics. According to X-Therma, the platform is designed to extend the storage and transport window of sensitive biologics for up to five days at sub-zero conditions without freezing. Tap the link in @coldchainplatfo
I spent the last few days at the Vitalist Bay Longevity Conference in Berkeley. Here are a few of my insights: - Organ preservation is quickly developing. Xiaoxi Wei, Ph.D., at X-Therma Inc.… | Karen Emily Muhwezi LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at a
#isct2026 #celltherapy #innovation #biopreservation #advancedtherapies #xtherma #dublin2026 | X-Therma Inc. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, yo … h it. We covered a lot of ground around the clinical translation and real-world application of novel cell therapy approaches; the promise, the complexity, and the honest realities of moving from bench to bedside. It's a journey that demands patience, precision, and an unwavering commitment to the patients at the center of it all. A few thoughts I'm still sitting with: → Innovation in this space is accelerating, but the gap between scientific possibility and clinical reality r
#jpm2024 #healthcareinnovation #biopreservation #xthermaatjpm | X-Therma Inc. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agr
X-Therma Celebrates Feature in USA Today's Kidney Health Special: 'Subzero Organ Preservation is Ready to Transform Transplantation' | The Organ Donation and Transplantation Alliance Login Menu Learning Programs & Collaborative Events Advancement Series Tue, Jun 30, 2:00pm Innovations in Advanced Organ Preservation: Next-Gen Kidney Perfusion Tue, Aug 11, 2:00pm Electronic Referrals: The Good, The Bad and the Ugly Thu, Aug 13, 2:00pm Heart Transplant Innovation: Expanding What’s Possible Upcoming On-Demand Conversation Series Tue, Jul 28, 2:00pm Closing Gaps: Understanding B … ison 1 All Jobs Continuing Education Credits Many of our learning opportunities award continuing education credits for the healthcare community of practice. More Details 2026 40 Under 40 Nominations Learn More Resources & Insights Educational Guides Terminology & Data References DCD Educational Guide Community Hospital Resource Guide Transplant Resource Guide Insights The Quality Corner Hospital Executive Insights Transplant Executive Insights Spotlight One-Pagers Il … f good news. Please share yours. A great idea? An inspiring tale? A well-earned award? It’s OK to brag. We all could use good news. Would you like to nominate someone from your organization who goes above and beyond? We celebrate front line heroes. Please fill out our form to let us know. Click Here to Share Navigate Professional Development Resources Events News Insights About Us Publications Organ Donation Textbook Donation After Circulatory Death (DCD) Educational Guide Te
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
X-Therma Inc. - Our CEO, Dr. Xiaoxi Wei is a featured... Facebook Log In X-Therma Inc.'s Post X-Therma Inc. February 8, 2021 · Shared with Public Our CEO, Dr. Xiaoxi Wei is a featured speaker in an upcoming ISBER webinar on Thursday, February 18 titled Ending COVID-19: The Vaccine, Technology, and Logistics Challenges. Registration is now open on the ISBER website at https://lnkd.in/gpD5dTF #cryopreservation #coldchainlogistics #regenerativemedicine register.gotowebinar.com register.gotowebinar.com All reactions: 6 Like Comment
X-Therma CEO Xiaoxi Wei's keynote at Rulebreaker Congress 2025 | X-Therma Inc. posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign … . in Trento. This scientific meeting will focus on translatome research and its application, examining the clinical impact of translation and potential target therapies. The event aims to foster collaboration among academic institutions, startups, and established companies. Dr. Gugnoni is scheduled to present her recent findings during the poster session on October 22nd, commencing at 7 pm. Her poster, "Linc00941: rewiring translation for malignant pleural mesothelioma resili
Speaker List - 2nd Annual MarketsandMarkets Cell-Gene therapy Bioprocessing Online Conference( Time Zone - EASTERN STANDARD TIME (EST) Discount Offer × Grab before it's gone. Avail 30% Instant Discount Look what we found for you. Use the code to avail 30% instant discount across all delegate participation opportunities. Get a chance to network with industry leaders and key decision makers. Learn from the best. Grow your knowledge exponentially. Please fill up the Enquiry Form to reveal the code. We Provide Market Research Consulting Services . Suggest a title & TOC, and get a customized … harles River Laboratories Xiaoxi Wei Founder & CEO, X-Therma Inc. Dr. Wei is an award-winning entrepreneur and chemistry professional in biomimetic nanoscience. She is recognized as a pioneering chemist in the field of cryobiology by her work on developing bioinspired ice-interactive molecules to advance the legacy cryopreservation technology in regenerative medicine. She founded X-Therma Inc. to pursue her 10-year passion and dedication to improve biopreservation for human h … elopment Manager, Cell & Gene Therapy , CPC Jayanthi Grebin has 20+ years as an Application and Technical Engineer in several different industries with the last 10 years focusing in product and business development for single use technology in Bioprocessing and Cell and Gene market. Margaret Temple Business Development Manager, SGS Margaret Temple has qualifications in genetics and business and has twenty-five years’ experience of client consultation to discuss and reco … systems, specializing in modern experimental design and analysis strategies and application of machine learning to science and engineering. In addition, Dr. Ramsey is a Professor in the Department of Mathematics and Statistics at the University of New Hampshire (UNH) where he teaches courses at the undergraduate and graduate level in design of experiments, machine learning, and statistical methods for quality improvement. He has held the following relevant industrial position … ion culture. Amritha Jaishanker Associate Director, MD Stem Cell Research Fund , TEDCO Dr. Jaishankar is the Associate Director of the MD Stem Cell Research Fund (MSCRF). In this role, she is responsible for MSCRF business development, scientific management and oversight of portfolio. She interacts with stem cell scientists across Maryland
Cold Chain Platform | News Feed | Cold Chain Cold Chain Platform Logo Subscribe News Pharma Cold Chain Logistics Packaging Monitoring Airlines / Airport GxP Events Interviews Articles Resources eBooks Videos CCP Directory Events Event Calendar Submit an Event Past Events Contact Us News › Cold Chain PAXAFE Raises $9M Series A to Transform AI-Powered, Autonomous Cold Chain Logistics www.coldchainplatform.com, May 17th, 2024 Thermo Fisher Scientific Launches New ENERGY STAR certified TSX Universal Series ULT Freezers www.coldchainplatform.com, April 10th, 2024 X-Therma's $22.4M Series B S
Exclusive | Behind the billionaire-backed longevity business — and the innovations that could help us live longer | X-Therma Inc. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue … strange reason (irony intended), we don’t get much training during neurosurgery residency or clinical practice towards the business side of running a neurotechnology startup. As a result, I’ve managed to experience all the challenges outlined in the “founder handbook” - picture the Blade Runner robot running in slow motion through a series of plate-glass windows. With many thanks to the visionary teams at KdT Ventures and PsyMed Ventures, very much looking forward to sharing … gn in Peter Eckman 8mo Report this post Highcroft Capital is eagerly working to fund Med Tech advances that intersect with clinical needs. Our physician-led fund invests in early-stage medical tech entrepreneurs and leverages our clinical experience to support the essential venture capital ecosystem. Anubodh Sunny Varshney, MD Heart Failure and Transplant Cardiologist, Medical Director of Mechanical Circulatory Support at Stanford | Venture Advisor at Broadview Ventures 8mo A
#jpmhealthcare #youhavetime #xtherma | X-Therma Inc. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy ,
X-Therma - BIO International Convention | BIO Skip to main content --> Policy Get Involved Join BIOAction View Advocacy Toolkit Patient Advocacy Human Health Cost and Value of Biopharmaceuticals Antimicrobial Resistance Vaccines & Biodefense Drug Development & Review International Global Markets & Trade Multilateral Organizations Intellectual Property Science & Regulatory All Policy Patient Advocacy Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access. Member Membership Options
X-Therma at BIO International Convention 2026: Regenerative Medicine Breakthroughs | X-Therma Inc. posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue … to secure your place at The Bioprocessing Network Conference 2026 in Sydney and submit your abstract before 15 July. The conference will bring together researchers, manufacturers, suppliers, and industry leaders from across Australia and beyond to discuss the latest developments in bioprocessing, biomanufacturing, advanced therapies, digital technologies, and manufacturing innovation. #BPN2026 Conference registration and abstract submission: https://lnkd.in/eBPKxr9Q If you ar
#vitalistbaysummit #biotechinnovation #longevityscience #organpreservation #futureofmedicine #xtherma #youhavetime | X-Therma Inc. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue
#vitalistbay #longevity #biopreservation #biotech #xtherma #youhavetime | X-Therma Inc. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’
X-Therma CEO Discusses Longevity and Biopreservation at Vitalist Bay 2026 | X-Therma Inc. posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join o … lowers 4w Edited Report this post Investment through the Biomedical Translation Fund is supporting Cynata Therapeutics to progress new generation mesenchymal stem cell (MSC) therapies towards commercial development. BioScience Managers is backing Cynata to develop these (MSC) therapies for osteoarthritis, diabetic foot ulcers, graft versus host disease and the prevention of transplant rejection. We deliver the Biomedical Translation Fund (BTF) on behalf of the Australian Gove … Ageing . Government and private investors have committed $501.25 million to the fund. Learn more about the investment in Cynata: http://spklr.io/6040EMbhI Australian Investment Council , Industry Innovation and Science Australia , Jeremy Curnock Cook , Kilian Kelly . #BTF #VentureCapital #Biomedical #Medtech #StemCellTherapies #InvestmentFunds …more Cynata Therapeutics and BioScience Managers 91 2 Comments Like Comment Share Copy LinkedIn Facebook X To view or add a comment, … ources 64,374 followers 4w Edited Investment through the Biomedical Translation Fund is supporting Cynata Therapeutics to progress new generation mesenchymal stem cell (MSC) therapies towards commercial development. BioScience Managers is backing Cynata to develop these (MSC) therapies for osteoarthritis, diabetic foot ulcers, graft versus host disease and the prevention of transplant rejection. We deliver the Biomedical Translation Fund (BTF) on behalf of the Australian Gove … Ageing . Government and private investors have committed $501.25 million to the fund. Learn more about the investment in Cynata: http://spklr.io/6040EMbhI Australian Investment Council , Industry Innovation and Science Australia , Jeremy Curnock Cook , Kilian Kelly . #BTF #VentureCapital #Biomedical #Medtech #StemCellTherapies #InvestmentFunds Cy
Welcome Dr. Xiaoi... - Coalition for Radical Life Extension Facebook Log In Coalition for Radical Life Extension's Post Coalition for Radical Life Extension is with X-Therma Inc. May 1, 2025 · Shared with Public Welcome Dr. Xiaoi Wei to RAADfest 2025! Dr. Xiaoxi Wei is an award-winning American entrepreneur and inventor renowned for her groundbreaking work in biomimetic nanoscience and biopreservation. Driven by a vision to enable "on-demand" organs, tissues, and cell products, she completed her Ph.D. in Biomimetic Chemistry at SUNY Buffalo, where she successfully managed $8 mil
Welcome Dr. Xiaoxi (Sofie) Wei (X-Therma Inc.) to RAADfest 2025! | James Strole LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User A … lowers 1y Welcome Dr. Xiaoxi (Sofie) Wei to RAADfest 2025! Dr. Xiaoxi Wei is an award-winning American entrepreneur and inventor renowned for her groundbreaking work in biomimetic nanoscience and biopreservation. Driven by a vision to enable "on-demand" organs, tissues, and cell products, she completed her Ph.D. in Biomimetic Chemistry at SUNY Buffalo, where she successfully managed $8 million in engineering projects. In 2014, Dr. Wei founded X-Therma Inc. , a venture-backed
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
Healthcare Issue 11 Mar 11 - Mar 17, 2024 Home About us Our Partners Newsletter Subscribe Contact Us More Home About us Our Partners Newsletter Subscribe Contact Us Home About us Our Partners Newsletter Subscribe Contact Us One Stop Platform for early to middle stage businesses One Stop Platform for early to middle stage businesses One Stop Platform for early to middle stage businesses One Stop Platform for early to middle stage businesses Newsletter Subscribe We will publish weekly newsletters of fundraising events. Sign up to hear from us. Email Sign up Social media Weekly Newsletter LXL Cap
%PDF-1.6 %���� 13569 0 obj > endobj 13588 0 obj >/Filter/FlateDecode/ID[ ]/Index[13569 31]/Info 13568 0 R/Length 102/Prev 1714455/Root 13570 0 R/Size 13600/Type/XRef/W[1 3 1]>>stream h�bbd```b``������ >stream h�b```� , ,� B cb��BFFJP`��d�� b)0N�5 8���=�1���Њ;Y�|��*�"|˱� lZ�wX��٩P�'�p6����D�^�驶��dN�[tCI�u݁_?4� 8ny�|��G��L� z��%/9o D?`�e� >/Metadata 469 0 R/Outlines 490 0 R/PageLayout/OneColumn/Pages 13540 0 R/StructTreeRoot 675 0 R/Type/Catalog/ViewerPreferences >>> endobj 13571 0 obj >/ExtGState >/Font >/ProcSet[/PDF/Text/ImageC/ImageI]/XObject >>>/Rotate 0/StructParents … 96c428e-4471-404a-9328-6c0f9cd906e5 uuid:239adc4a-76bc-489e-9641-ef1d693d8ab4 3 application/pdf How IRS section 174 threatens America’s most innovative small business Case Studies Holden McLaughlin Adobe PDF Library 23.8.246 D:20240117122107 Case Studies endstream endobj 470 0 obj >stream hޜ��n1D�����-E�p�E��HD� � ��Ƌ�(��2�Z��=vUyEm�)'�oIEF�$^G� [T[R�QY�$&x�Z�(� FU�{�k����Tu�f�lT}t�1y �[�D�6�> u�cޟ���6+Y��t4g �Ӽ�(6�ޟU����ь�O�yt�[/�h�-AjL�xL+ �ۻ�9����ۯ�������>�v�
%PDF-1.4 % ���� 4 0 obj > /PageLabels > ] >> /Outlines 2 0 R /Pages 1 0 R >> endobj 5 0 obj > endobj 6 0 obj > >> endobj 7 0 obj > stream x��[َ$G�?�#�Ƀ�t��#Hd�M #,?Xf1P3����9�ި��ʲ�Ok��OgFܸ�����/�̯��"���_�9uv�s���]�;���&�xs�%������Kp�&^\λ_����'������������� �p��c 9�e>��p�jK�����h�/����#|�lع]�W�,��b�8x�-l��.+\�����{1!%��#`@���m ې�z% ������ Da�P��A�/�p����������������Y�"���%tY�Iu���wO?;�����c|� �^��p���g`�>}"��N ���W��_?�� ���阔��G�͡C�ɿt�4m���N|=���j�О�#�ZR� �����6��r�R�QZ\R#��"��\�F�$归 ��4 �CtY��Z���=���� >��ۿ}����\�������o�����o���S�q��ɀ6N���R6���"ۿ�G.��� … �3�p؈ׇ2ߨQE�tQ@Q@Q@Q@���/m��Y�$( O��GJ�4P����FI�s�T4=;�6��q��f��RFp8� ~I�� ��� �zw����#�1؟o;Ge�\(����I4�`Ny���f>����㲥HӋ��G$!*�Q��y{mb��r�j��%�3�?��d��u]^�Q%$m����C�8���~���A��M�]4�n ���v�/ussi j ]��� �N�pp3T��u(c(�L��bdUv�Ձ?�l�Q��A���FK�t'u�j��Fl�i߇MĞ@ ���b��k���&indi ��s��z*�1U�j��U�=�5'F��w�QE�nQEQEQEQEQEv �)��u�"YL[q�h?���[����'Ht�;����nW��RXx[����y_�QE>������5ԕݑ�ݵ K���o��������� \��|��R�3*��X������+����3ƺ\v� 5�)�*�?��6�g … G..�6�Ymv���b�o��0ON9����e�.�O kz�9��I��s�s� ����v�_�� �?�.���sy�]�\jW�y�rFp�8 �g8����x ��}��+����ݯ���R����]�M���].�gdlRW�d;� d��g_i��^y�|'д��7�:�[�Ԯ��!��Q�� ��rp{��;��^�����2���e�J��8�n����V��կ�b�[� �-��-�5Y� ��� ��7���o��߈~mW�xa�t� ��� ��|!�?�x�ᧆ�A��:ׇu�����J���&p �P Ӝ|9�W�x��Q���R��'Ե |��wPp s�I����(��(��(��(��(��(��(��(��(��(��(��(��(��(��(��(��(��(���[��A�]gF�����e5�����!]�r3���Es �*|�}/æ�_u�@��ߺF������zWOEQEQEQE … �����#���uMF�ll��{=̊���'$� ���i֧iI&yѥ9��\�h��Ѐ��(�KY��prO����U�W���-ݔ��H�rFp{ { kʫ��� �(��Ió���w�t�������.�]�ۻ>@3m�G����s�1_���?�_��/� '��A��뗯6_?n����� ��QE����(��(�fo�����7�w������� �A��������gS����PQE�� u���I���w��B��+�����N��_�|�__��?W� 5� �z����Hht_L[M'l y�?�o�?�ӧ����2��FA ��r�w��ã�Z/�&-��� �96�������t��2�{֢����l�0�*�N�� �E`�He# ��E-|��Q@ ��|�{�ps��ZF?7A���+�+�J��? s�����^��1���?\�����yüE���/�����PH ��)(�c��>�M��C�ؼKk�?�����_c … į k��u��6�d�s�G�L��)��'�#����s� U�|g�E��.�y��$~r�,�*c����f��8� x�� _�_��(b�E�RFp|� �?�q�(�S���ҟD����>�����6��d�X�$� m�@;���G�:�q-ܢZ9� !8T�j�c� Oj���Z�>���㱁 %���k���E���$�y�-5I. w�����u�w�^��K�I����s����"��� �7���c�%��3ۼ�m�ʛCnW�0�`�0y�u��?�=rO �.��ñE��b���Kx$?,1��{���~0G5���o� �j� �R�,5 ��ʒ���>����^__x��D���q�j�,�� z���{���
PK!�^/��[Content_Types].xml �(��U�n�0��?� (��rI{l$�F I������ 2�Q� �ڋ$.o�q8��ءXAD�]-(�5^����ˏ�(���j�j���O��m,��=Q�&%6=X���x���*�a�dP�Bu ����xGਤ�!�Gh�r�����ߜ�'���}I�*��4�ب\9�N��mkоYZ��0DP{�C�a�� D 9� �}�il�)��8&�n��� �CG�N�����r}�> ���gߪ� L� ��ء?(r���ܐn zD[�k���PK!�U0#�L _rels/.rels �(���MO�0 ��H�����ݐBKwAH�!T~�I����$ݿ' T�G�~���� �]��\� B�ނ!W+��X�UɄف(VP�u�A+ӷ��T=Vk7�� ����EN���!]��t���o~��7��t�䩒Z��@{;���r���eކ��{�� �T������ �?�F@Z�VBH�;�:n>]�x��w�u�z����� �T���� Q�r�^:�Q�:�xV��~y���g &p���0%�a)
Instagram Instagram Log In Sign Up Close Never miss a post from pharmashot Sign up for Instagram to stay in the loop. Sign up Log in pharmashot • Follow More options pharmashot 1w Inhibrx’s Ozekibart BLA accepted by FDA for unresectable or metastatic conventional chondrosarcoma, backed by pivotal ChonDRAgon data showing 52% reduction in risk of progression or death #inhibrxbioscience #pharmashots #news Load more comments No comments yet. Start the conversation. Like 2 Comment Share Save June 17 Log in to like or comment. More posts from pharmashot Clip Clip See more posts Meta About Blog Jobs
X-Therma Brings Biomimetics to Bioprocessing genprowebdirectory End Meta Pixel Code --> Facebook Linkedin RSS Twitter Youtube GEN Edge Featured News Multimedia Content News Insights Topics Artificial Intelligence Bioprocessing Cancer Drug Discovery Genome Editing Infectious Diseases OMICs Translational Medicine Magazine Browse Issues Subscribe Multimedia Summits Webinars GEN Live Learning Labs Podcasts Videos Resources A-Lists eBooks/Perspectives Tutorials Peer-Reviewed Journals GEN Biotechnology Re:Gen Open New Products Subscribe Get GEN Magazine Get GEN eNewsletters Search Facebook Linkedin
X-Therma Showcases Groundbreaking Organ Preservation Technology at Johns Hopkins' "Hopkins on the Hill" Event - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News X-Therma Showcases Groundbreaking Organ Preservation Technology at Johns Hopkins’ “Hopkins on the Hill” Event July 2, 2025 by Isaac Arruda X-Therma proudly announces its participation in the prestigious Hopkins on the Hill event, held on June 11, 2025, in Washington, D.C. The biennial event sho
X-Therma Overview, Address & Contact Login Get Started X-Therma Biotechnology Research • Innsbruck, Tyrol, Austria • 1-10 Employees View Top Employees At X-Therma Company overview Headquarters Innsbruck, Tyrol, Austria Website x-therma.com NAICS 541714 SIC 873 Employees 1-10 Socials Emails Format About Revenue Employees Insights Funding Trending Companies FAQ X-Therma Email Formats X-Therma uses 2 email format s . The most common is {first name}{last name} (e.g., [email protected] ), used 85.7 % of the time. Format Example Percentage {first name}{last name} [email protected] 85.7 % {
X-Therma Raises $22.4 Million in Series B Funding to Revolutionize Regenerative Medicine and Extend Organ Preservation 26 June, 2026 | Friday BioPharma America BioPharma Europe BioPharma Middle East BioPharma Africa BioPharma APAC Events Media Pack Login BioPharma Pharma & Biopharma Manufacturing Pharma Research Pharma QC Clinical Trials Drug Discovery Drug Approval BioSimilar Pharma Packaging LAB LAB Business LAB Health & Safety LAB Products LAB Design&nb
Nanotech Planet - Xiaoxi Wei, Ph.D. Co-founder & CEO of... Facebook Log In Nanotech Planet's Post Nanotech Planet July 29, 2022 · Shared with Public Xiaoxi Wei, Ph.D. Co-founder & CEO of X-Therma Inc.; User Affiliate at Lawrence Berkeley National Laboratory. Dr. Wei is an entrepreneur and chemistry professional in the area of supramolecular assembly and biomimetic nanoscience. Like Comment
X-Therma Inc. News | X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us X-Therma's Latest News Read the latest news about X-Therma, Cryopreservation and Biopreservation. Filter By Category: XT-Thrive XT-ViVo & TimeSeal Filter By Topic: Cryopreservation Organ Preservation X-Therma Showcases Groundbreaking Organ Preservation Technology at Johns Hopkins’ “Hopkins on the Hill” Event July 2, 2025 X-Therma proudly announces its participation in the prestigious Hopkins on the
Invest In X-Therma Stock | Buy Pre-IPO Shares | EquityZen We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences Sign Up Today and Learn More About X-Therma Stock Invest in or calculate the value of your shares in X-Therma or other pre-IPO companies through EquityZen's platform. Get Started View More Companies X-Therma Stock (XTHE) X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine. Invest Now Sell Shares About X-Therma Stock Founded 2014 Headquarters Richmond, CA, US I … their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investmen … on FINRA’s BrokerCheck . EquityZen Inc. was awarded a 2024 Fintech Breakthrough Award by Tech Breakthrough LLC on March 19, 2025, based on the prior year and covering calendar year 2024, and has compensated FinTech Breakthrough LLC for use of its name and logo in connection with the award. FinTech Breakthrough LLC is a third party and has no affiliation with EquityZen. EquityZen created the ticker symbols referenced on this page for use solely on the EquityZen platform. They
--> --> X-Therma jobs, careers, overview, and news by VentureLoop --> --> --> --> MENU Toggle navigation Home Job Search internships --> blog widget --> Login --> --> X-Therma 0 Job Address 2600 Hilltop Drive, Richmond, CA 94806 Website www.x-therma.com Est. Since 2014 Investors QB3 About --> About X-Therma X-Therma develops novel, convergent chemical technologies in biopreservation to advance the field of regenerative medicine by making available safe and on-demand organs for transplant, engineered tissues, and cell therapies for the patients in need. The Company is devoted to lead innovation
X-Therma | Biotech Careers Skip to main content Biotech Careers Contact Submit an Employer Contact Add an Employer Search Open main menu Contact Submit an Employer Contact Add an Employer Search Main navigation Careers Job Areas People Articles Videos Biotech Companies Biotech Jobs Business Areas X-Therma Website: X-Therma Business Area(s) Regenerative Medicine Description X-Therma supports regenerative medicine by cryopreserving tissues for extending time. Career Page(s) Careers Why X-Therma? Jobs Company Location(s) 2600 Hilltop Drive Richmond , CA 94806 United States body Sign up for news C
Revolutionizing organ preservation and transplantation by mimick… Sign up to get updates from us ... By signing up, you agree to receive email from this podcast. Subscribe Lab to Startup Episodes About Contact Reviews All Reviews Leave a Review Rate on Apple Podcasts Rate on Spotify Follow Apple Podcasts Spotify Amazon Music RSS Feed Search Follow Apple Podcasts Spotify Amazon Music RSS Feed Search Sept. 6, 2022 Revolutionizing organ preservation and transplantation by mimicking antifreeze proteins of Arctic fish Xiaoxi Wei, Ph.D (CEO) and Mark Kline, Ph.D. (CTO) are the cofounders of X-Therma … CRISPR delivery problem using a proprietary peptide-based platform Altitude Lab Fund- Supporting healthcare founders in challenging times Partnering to accelerate therapeutics: A primer on forming alliances and their management From Pitches to Stories: Transforming Complex Ideas into Engaging Narratives Turning great science into impactful medicine: Lessons from Corey Goodman, Pioneer in Science and Venture Capital Pushing Boundaries: Abhishek Tripathi’s Experience with NASA,
Jobs at X-Therma Inc. | VU Venture Partners You are using an outdated browser. Please upgrade your browser to improve your experience and security. Home About pitch Fund Portfolio Team News Jobs Contact Invest With VU Powered by Consider Privacy Terms
X-Therma Closes Oversubscribed $13M Series A Financing Led by LOREA AG - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Bay X-Therma Closes Oversubscribed $13M Series A Financing Led by LOREA AG December 22, 2021 | 5 min read Twitter LinkedIn Facebook Email Print X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation - has closed an oversubscribed $13M Series A f … the Lawrence Berkeley National Laboratory and received over $10M contracts and grant support from the U.S. Department of Defense, the National Science Foundation, and the California Institute for Regenerative Medicine. View source version on businesswire.com: https://www.businesswire.com/news/home/20211222005044/en/ Contacts CG Life Lauren Stredler [email protected] +1(847) 271-6891 Source: X-Therma Inc. View this news release online at: http://www.businesswire.com/news/h … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
eGenesis to Participate at BIO International Convention 2026 Panel on the Future of Xenotransplantation - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases eGenesis to Participate at BIO International Convention 2026 Panel on the Future of Xenotransplantation June 19, 2026 | 2 min read Twitter LinkedIn Facebook Email Print CEO & President Mike Curtis joins industry leaders to discuss the clinical progress and potential of xenotransplantation to address t … when you subscribe to GenePool! MORE ON THIS TOPIC Podcast AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more June 24, 2026 · 1 min read · Jef Akst BioSpace at BIO to find out" href="https://www.biospace.com/drug-development/can-adcs-be-kinder-and-gentler-join-biospace-at-bio-to-find-out" > Antibody-drug conjugate Can ADCs be kinder and gentler? Join BioSpace at BIO to find out June 23, 2026 ·&n … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
X-Therma Receives FDA Breakthrough Device Designation for XT-ViVo® Preservation Solution and TimeSeal® Organ Transport Device - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Bus … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Bay X-Therma Receives FDA Breakthrough Device Designation for XT-ViVo® Preservation Solution and TimeSeal® Organ Transport Device May 3, 2022 | 3 min read Twitter LinkedIn Facebook Email Print X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservati … the Lawrence Berkeley National Laboratory and received over $11M contracts and grant support from the U.S. Department of Defense, the National Science Foundation, and the California Institute for Regenerative Medicine. The company recently closed an oversubscribed Series A of $13M. View source version on businesswire.com: https://www.businesswire.com/news/home/20220503005010/en/ Contacts CG Life Lauren Stredler [email protected] Source: X-Therma Inc. View th … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA) - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Bay X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA) April 17, 2024 | 2 min read Twitter LinkedIn Facebook Email Print X-Therma Inc , announces that the Food and Drug Administration (FDA) accepted a Drug Master File (DMF) covering its product, XT-Thrive ® . … reference the DMF in their Investigational New Drug (IND) and Biologics License Application (BLA) submissions to the FDA for products in the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). XT-Thrive ® is a DMSO-free, serum-free, protein-free, and chemically defined cryopreservation media enabling the preservation of mammalian cells at ultra-low temperatures (-70° C to -196° C). It incorporates a fundamentally new cla … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
X-Therma Launches XT-NoVo® & TimeSeal® Platform: Shattering Cold Chain Barriers for On-Demand Regenerative Medicine - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases X-Therma Launches XT-NoVo® & TimeSeal® Platform: Shattering Cold Chain Barriers for On-Demand Regenerative Medicine June 10, 2026 | 3 min read Twitter LinkedIn Facebook Email Print HERCULES, Calif. , June 10, 2026 /PRNewswire/ -- X-Therma Inc., a pioneering biotechnology company focused on revolutioni … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
X-Therma Welcomes Biotech Veteran Neil Warma to its Board of Directors - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases X-Therma Welcomes Biotech Veteran Neil Warma to its Board of Directors June 11, 2025 | 5 min read Twitter LinkedIn Facebook Email Print HERCULES, Calif. , June 10, 2025 /PRNewswire/ -- X-Therma Inc ., a pioneering biotechnology company focused on revolutionizing regenerative medicine through its innovativ … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
X-Therma's $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Bay X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation March 13, 2024 | 5 min read Twitter LinkedIn Facebook Email Print X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an ove … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Brex Launches Partnership With BIO - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releas … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Business Brex Launches Partnership With BIO November 12, 2019 | 3 min read Twitter LinkedIn Facebook Email Print Brex Bolsters Its Life Sciences Offering by Partnering With Premier Trade Association Nov. 12, 2019 14:00 UTC SAN FRANCISCO--( BUSINESS WIRE )-- Brex , the financial technolog … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
X-Therma Achieves GMP Commercial Readiness with XT-Thrive® - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releas … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Bay X-Therma Achieves GMP Commercial Readiness with XT-Thrive® May 29, 2024 | 3 min read Twitter LinkedIn Facebook Email Print X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has achieved GMP commercial readiness with its flagship produc … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Jobs at X-Therma GmbH | JOIN X-Therma GmbH 11-50 employees Medical Equipment Manufacturing Website LinkedIn Open positions 1 Offices Open positions Department All departments Location All locations Usability & Industrial Designer for Medical Hardware Devices (m/f/d) Innsbruck, Austria (hybrid) Employee Product Design, Industrial Design 42.000 € / year 1 of 1 results Offices 1 job ad X-Therma GmbH Langer Weg 11 6020 Innsbruck Austria WE HIRE WITH JOIN Terms & conditions Privacy policy Report issue Home Jobs at X-Therma GmbH
Posts with replies by X-Therma Inc. (@X_Therma) / X Log in Sign up X-Therma Inc. @X_Therma X-Therma Inc. solves unsolved cold storage and transport problems for cell and gene therapy and organ transplants. Biotechnology Company Hercules, CA x-therma.com Joined February 2016 60 Following 287 Followers Posts Replies Media
X-Therma - BIO International Convention | BIO Skip to main content --> Policy Get Involved Join BIOAction View Advocacy Toolkit Patient Advocacy Human Health Cost and Value of Biopharmaceuticals Antimicrobial Resistance Vaccines & Biodefense Drug Development & Review International Global Markets & Trade Multilateral Organizations Intellectual Property Science & Regulatory All Policy Patient Advocacy Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access. Member Membership Options
Page not found - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Viewing by: It seems we can't find what you're looking for. X-Therma, Inc. North America 625 Alfred Nobel Drive Suite B Hercules, CA 94547 USA Europe X-Therma GmbH Langer Weg 11 6020 Innsbruck Austria [email protected] Request information on products Imprint Data Policy Whitepaper Site by Cookson Imprint Data Policy Whitepaper Site by Cookson Cookie Consent We use cookies to improve your experience on our site. By
LIFTT investe in X-Therma, biotech americana che estende il tempo di conservazione degli organi - LIFTT Salta al contenuto Focus Portfolio Investors Team Pitch now News News LIFTT Technology Insights Press Coverage Media Centre Focus Portfolio Investors Team Pitch now News Technology Insights Press Coverage EN 24 Ottobre 2024 LIFTT investe in X-Therma, biotech americana che estende il tempo di conservazione degli organi Categorie: INVESTMENTS Il primo trasporto di organi sottozero al mondo: un rivoluzionario trasporto transatlantico di 48 ore dona speranza nel fronteggiare le liste d’att
New Published Article in Bone Marrow Transplantation - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News Cryopreservation , XT-Thrive New Published Article in Bone Marrow Transplantation July 1, 2021 Arthi Shridhar What a great way to wrap up our collaborative work with Vitalant Research Institute , Marcus Muench , Philip Norris in Bone Marrow Transplantation , a Nature Journal! Looking for DMSO- and Serum-free alternative cryopreservation media that is process friendly, safe to use, a
Welcome to the X-Therma team LIFTT! | Mark Kline LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and
Imprint - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Imprint X-Therma Inc. 2600 Hilltop Drive Suite B220 Richmond, CA 94806 X-Therma GmbH Kaiserjägerstraße 30 A-6020 Innsbruck FN 564408 m ATU77414308 Email: [email protected] Management: Mark Kline, Ph.D. Xiaoxi Wei, Ph.D. X-Therma, Inc. North America 625 Alfred Nobel Drive Suite B Hercules, CA 94547 USA Europe X-Therma GmbH Langer Weg 11 6020 Innsbruck Austria [email protected] Request information on products Imprint Data Policy Whit
Xiaoxi Wei - Executive Bio, Work History, and Contacts - Equilar ExecAtlas Request a Demo Engage Executives. Unlock Deals. ExecAtlas delivers real-time insight into who-knows-who, paving the way for warm introductions that create opportunities. Search for an Executive Trusted by Industry Leaders Trusted by Industry Leaders Featured Profile Xiaoxi Wei CEO & Co-founder at X-Therma Inc. Xiaoxi Wei 's Executive Work History Current CEO & Co-founder , CEO & Co-founder Equilar on 03/24/2026 X-Therma Inc. Past To view Xiaoxi Wei's complete executive work history, sign up now Education Ph. … lo - SUNY, School of Law, Dean’s Advisory Council Xiaoxi Wei 's Biography is an award-winning American entrepreneur and inventor in the area of biomimetic nanoscience and biopreservation in Regenerative Medicine. Being persistent in her life vision to enable “on-demand organs” from a very young age, she pursued her scientific endeavor in biomimetic Chemistry at SUNY Buffalo, earning her doctorate. Inheriting the entrepreneurial spirit from her family, she successfully managed … lo - SUNY, School of Law, Dean’s Advisory Council Xiaoxi Wei 's Biography is an award-winning American entrepreneur and inventor in the area of biomimetic nanoscience and biopreservation in Regenerative Medicine. Being persistent in her life vision to enable “on-demand organs” from a very young age, she pursued her scientific endeavor in biomimetic Chemistry at SUNY Buffalo, earning her doctorate. Inheriting the entrepreneurial spirit from her family, she successfully managed
Johannes Weggemann - Executive Bio, Work History, and Contacts - Equilar ExecAtlas Request a Demo Engage Executives. Unlock Deals. ExecAtlas delivers real-time insight into who-knows-who, paving the way for warm introductions that create opportunities. Search for an Executive Trusted by Industry Leaders Trusted by Industry Leaders Featured Profile Johannes Weggemann Chief Financial Officer at X-Therma Inc. Johannes Weggemann 's Executive Work History Current Chief Financial Officer , Chief Financial Officer Equilar on 03/24/2026 X-Therma Inc. Past To view Johannes Weggemann's complete executiv
X-Therma Team Excellence | X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Meet the Team Xiaoxi (Sofie) Wei, Ph.D CEO & Co-founder LinkedIn is an award-winning American entrepreneur and inventor in the area of biomimetic nanoscience and biopreservation in Regenerative Medicine. Being persistent in her life vision to enable “on-demand organs” from a very young age, she pursued her scientific endeavor in biomimetic Chemistry at SUNY Buffalo, earning her doctorate. Inheriting the entrep … edical devices, is (co-)inventor of more than 25 patents, (co-)originator of 28 award-winning industrial designs and shares his thought leadership in “phygital product development” as lecturer and faculty member. Andreas lives in Munich and orchestrates business, technological and human factors in the development of our hardware products. Board Members Xiaoxi Wei, Ph.D. Chair, Chief Executive Officer LinkedIn Mark Kline, Ph.D. Member, Chief Technology Officer Link … e Group. Former Managing Director of Eastman Ventures, a top-quartile corporate fund. Rodney W. Turner LinkedIn An experienced executive in life science tools companies, Mr. Turner has spent most of his career in leadership roles, with a focus on corporate development and M&A, as well as an advisor to private equity and venture capital groups. He has served and continues to serve as a director on the boards of companies in the US and Europe. He is currently the Head of Gl
About - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Removing Time from the Equation X-Therma enables the robust preservation of cells, tissues, organs, and other biologics by leveraging our proprietary peptoid . The peptoid inhibits lethal ice crystals, allowing long-term sub-zero storage of biological materials while maintaining unparalleled functionality and viability. Our Values How it Began When she was 8 years old, Xiaoxi’s beloved grandfather passed away. If he had receive … k for X-Therma at Lawrence Berkeley National Laboratory. She received her first grant awarded to X-Therma. Provisional patent filed. 2016 Only one year later X-Therma had two additional grants in implementation and a team of four. First successful proof of concept for novel preservation of cell lines. 2017 X-Therma now has five grants running simultaneously and filed additional provisional patents. 2018 X-Therma partnered with Johns Hopkins University and Dr. Gerald Brandache
Next-Generation Cryopreservation Techniques: Improving Cold Chain Management For Regenerative Medicines - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News Next-Generation Cryopreservation Techniques: Improving Cold Chain Management For Regenerative Medicines July 27, 2023 by Isaac Arruda Cryopreservation has become a crucial component in realizing the large-scale commercial manufacturing of regenerative medicines, which require unique storage and transport strategies to ensure their e
X-Therma's $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Gallery All Multimedia All … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
X-Therma was awarded the global health prize from bayer - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News X-Therma was awarded the global health prize from bayer March 10, 2019 Arthi Shridhar “Throughout the year, Hello Tomorrow partners with top universities, research labs, accelerators and incubators around the globe to find entrepreneurs at a very early-stage who are developing new scientific and technological solutions. This year, the Global Challenge saw a record of 4,500 applic
Science Chops Alone Don’t Cut It: The Entrepreneurial Growth Struggle - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News Science Chops Alone Don’t Cut It: The Entrepreneurial Growth Struggle August 23, 2023 by X-Therma Team In the eight years since launching X-Therma, we’ve achieved chemistry breakthroughs that we believe will truly propel the field of organ transplant to a new era. But learning hasn’t taken place solely in the lab; for me, the last eight years have been an education
X-Therma | MTEC MTEC Focus Areas Who we serve Solicitations Patents About Us Explore Join MTEC Log In Life Sciences / Companies X-Therma X-Therma pioneers a breakthrough biopreservation platform, transforming “living” medicines into on demand treatments. They develop innovative solutions to extend the preservation time of cells, tissues, and organs at below-freezing temperatures, aiming to improve patient outcomes and address global organ availability issues. Their mission is to create time by emulating and improving upon natural processes to enable long-term storage and transportation of biol … R Final, Silicon Valley X-Therma Inc. received 1st place in the 2018 SVIEF Star Award competition. Similar organizations Browse all ORGANIZATIONS JOIN OUR MAILING LIST Stay Connected with MTEC Keep up with active and upcoming solicitations, MTEC news and other valuable information. MTEC For federal agencies Focus Areas Technology Showcase Member Directory Events For innovators and service providers Member Directory Submitting Proposals Active Solicitations How to Join For hea
Jobs - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us We believe in investing in people and building meaningful relationships People are the heart and soul of X-Therma. Without our team we would not be able to make strides towards accomplishing our goals. This is why we invest in people and equip them with the tools and skills they need to grow and take on bigger challenges. Apply Now! We’re excited that you’re applying to X-Therma, and we can’t wait to learn more about
X-Therma's $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation March 13, 2024 by Isaac Arruda X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an oversubscribed $22.4 million Series B funding round. Imag
Biotechnology Jobs | X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Careers X-Therma is on a mission to improve patient outcomes by providing preservation without compromise. Together we can ensure a world where we have Time . Our work is truly cross disciplinary, bringing together a multitude of disciplines including biology, chemistry, and engineering. We 🫀 X-Therma There’s a million and one reasons we enjoy working at X-Therma. Here’s a few… See Why Join our T
Biotechnology Jobs | X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Careers X-Therma is on a mission to improve patient outcomes by providing preservation without compromise. Together we can ensure a world where we have Time . Our work is truly cross disciplinary, bringing together a multitude of disciplines including biology, chemistry, and engineering. We 🫀 X-Therma There’s a million and one reasons we enjoy working at X-Therma. Here’s a few… See Why Join our T
Fixing The Regenerative Medicine Supply Chain - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News Fixing The Regenerative Medicine Supply Chain May 1, 2023 by Arthi Shridhar In the past few years, specifically through the COVID-19 pandemic, supply-chain vulnerabilities have become the topic of everyday conversation across all industries— not just among manufacturing CEOs but also everyone from consumers who had to wait months for a new washing machine to healthcare providers unable to
Page not found - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Viewing by: It seems we can't find what you're looking for. X-Therma, Inc. North America 625 Alfred Nobel Drive Suite B Hercules, CA 94547 USA Europe X-Therma GmbH Langer Weg 11 6020 Innsbruck Austria [email protected] Request information on products Imprint Data Policy Whitepaper Site by Cookson Imprint Data Policy Whitepaper Site by Cookson Cookie Consent We use cookies to improve your experience on our site. By
Instagram Instagram Log In Sign Up Close Never miss a post from benevskinscience Sign up for Instagram to stay in the loop. Sign up Log in benevskinscience and 3 others More options benevskinscience 6w Dr. Suneel Chilukuri shares why safety comes first in RF microneedling. From FDA awareness to pulsed wave technology, discover how advanced protocols help delivering effective results with Sylfirm X by BENEV. ✨ #BENEV #SylfirmX #RFMicroneedling #AAD2026 #RegenerativeAesthetics Disclaimer: Sylfirm X® (U.S. FDA 510K #K213612 ) is indicated for use in dermatologic and general surgical procedures fo
X-Therma Showcases Groundbreaking Organ Preservation Technology at Johns Hopkins' "Hopkins on the Hill" Event Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Galler … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
X-Therma Achieves GMP Commercial Readiness with XT-Thrive® - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News X-Therma Achieves GMP Commercial Readiness with XT-Thrive ® May 29, 2024 by Isaac Arruda X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has achieved GMP (Good Manufacturing Practice) commercial readiness with its flagship product, XT-Thrive®. X-Therma Inc. , a biotechnology company developing a breakt
Page not found - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Viewing by: It seems we can't find what you're looking for. X-Therma, Inc. North America 625 Alfred Nobel Drive Suite B Hercules, CA 94547 USA Europe X-Therma GmbH Langer Weg 11 6020 Innsbruck Austria [email protected] Request information on products Imprint Data Policy Whitepaper Site by Cookson Imprint Data Policy Whitepaper Site by Cookson Cookie Consent We use cookies to improve your experience on our site. By
New UB grant helps small businesses grow - UBNow: News and views for UB faculty and staff - University at Buffalo Skip to Content (UB) University at Buffalo (UB) UBNow News and views for the UB community Toggle Navigation Menu Top Choices Full Menu 6/12/26 Campus 6/12/26 Research 10/11/24 Your Colleagues 10/11/24 Working at UB 6/9/25 UB Seen 5/5/26 Driven to Discover Podcast 6/12/26 Campus 6/12/26 Research 10/11/24 Your Colleagues 10/11/24 Working at UB 6/9/25 UB Seen 5/5/26 Driven to Discover Podcast 10/11/24 Your Collegues 10/11/24 Working at UB 6/9/25 UB Seen Search UBNow > Stories > … ues 10/11/24 Working at UB 6/9/25 UB Seen Search UBNow > Stories > New UB grant helps small businesses grow Research News New UB grant helps small businesses grow By GROVE POTTER Published October 20, 2016 This content is archived. Share This Print “It’s a terrific opportunity for promising companies to grow their businesses with UB as a partner. ” Venu Govindaraju, vice president for research and economic development Five scientific companies have been awar … their research capabilities by partnering with the university. And UB hopes to award many more. The grants — called the UB Small Business Innovation Awards (SBIA) — are designed to help link companies with UB, where they can access world-class scientists, engineers and facilities that can enhance small business research and development programs. The UB award is available to any company that has qualified for a federal Small Business Innovation Research (SBIR) gra … s Innovation Research (SBIR) grant or Small Business Technology Transfer (STTR) grant. Qualifying companies that subcontract at least 30 percent of the federal grant to UB may receive up to a 20 percent SBIA match to fund additional work by the UB research team. The five firms benefitting from the new award — which goes toward work being conducted at UB by a UB researcher — are: Abcombi Biosciences , a UB spinoff that is developing products including a therapy for … ding a therapy for drug-resistant flu strains. Abcombi received a $300,000 STTR grant from the National Institutes of Health, and UB has awarded the company $35,039 through the SBIA program. Abcombi will work on research and development with UB faculty members Paul Knight, SUNY Distinguished Professor of Anesthesiology, and Microbiology and Immun
Firm | SBIR Skip to main content Skip to main content An official website of the United States government Here’s how you know Here’s how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Menu Contact Us Login Register Dashboard Login Please choose from one of the login options below: External User Login SBA Employee Login About Learn how … Archive Portfolio Interact with our SBIR/STTR portfolio’s data sets Portfolio - Award Data Portfolio - Company Data API Documentation Data Resources Data Dictionary Apply Better understand the application process and eligibility Apply Find Topics and Solicitations Frequently Asked Questions (FAQ) Lab to Market Hub Program Tutorials Community Stay connected with our innovation ecosystem Community Event Spotlight News and Events Newsletter Sign-up Federal and State Technology ( … vents Newsletter Sign-up Federal and State Technology (FAST) Growth Accelerator Fund Competition (GAFC) Company Portfolio Data Back to Company Search X-Therma Inc. Address 2600 Hilltop Dr # B229 Richmond, CA, 94806-1971 USA View website UEI: MKP9GFAJNEY9 Number of Employees: 2 HUBZone Owned: No Woman Owned: Yes Socially and Economically Disadvantaged: Yes SBIR/STTR Involvement Year of first award: 2015 4 Phase I Awards 5 Phase II Awards 125% Conversion Rate $679,562 Phase I D … ent awards are being displayed. To view all of this company's awards, visit the Award Data search page. Greatly Extended Subzero Ischemic Storage of Renal Allografts Using Novel Bio-inspired Next Generation Cryoprotectants Amount: $1,986,927 Topic: 400 Abstract: Organ preservation remains a daunting challenge. Organ specific ischemia windows of 4-24h greatly limit the field of organ transplantation to save lives and cause severe geographic restriction in the US an … unt of available organs for transplant. The goal of this Direct-to-PhaseII SBIR proposal is to establish the pre-clinical use of XT-ViVo for the non- frozen, subzero ischemic preservation and transplantation of renal allografts leading to improved outcome in comparison to static cold storage and to render greatly extended CIT of up to 120h possib
A Breakthrough Biopreservation Platform | X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us A Biopreservation Platform Without Compromise X-Therma enables the robust preservation of cells, tissues, organs, and other biologics by leveraging our proprietary peptoid . The peptoid inhibits lethal ice crystals, allowing long-term sub-zero storage of biological materials while maintaining unparalleled functionality and viability. Out products are chemically defined, as well as DMSO-free, serum-fr
Chief of Staff H1B Visa Salary & Sponsorship Data | H1BTrends H1BTrends H1B PERM Reports Green Card Calculator NEW H1B Lottery Odds Calculator (FY 2027) Immigration Updates Loading job title data... Analyzing H1B applications across companies Fetching applications Calculating statistics Preparing insights H1BTrends Search 3M+ H1B LCA and PERM labor certification applications from the U.S. Dept. of Labor. Find H1B sponsoring companies, compare salaries by job title and city, check approval rates, and explore employment-based green card data. Data reflects the most recent five fiscal years o
How X-Therma is fundamentally changing organ transplants - Bio.News Skip to content About Contact Bio.News Homepage Health Federal Policy State Policy Biosecurity International BIO’s View BIO Events Bio.News Homepage Health Federal Policy State Policy Biosecurity International BIO’s View BIO Events How X-Therma is stopping the clock – and fundamentally changing organ transplantation November 14, 2023 / Editors' Choice , Health , Latest News / By Colleen Pietras, M.D. Facebook Twitter/X Linkedin Did you know that every 10 minutes, a new person is added to the organ transplant w
Page not found - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Viewing by: It seems we can't find what you're looking for. X-Therma, Inc. North America 625 Alfred Nobel Drive Suite B Hercules, CA 94547 USA Europe X-Therma GmbH Langer Weg 11 6020 Innsbruck Austria [email protected] Request information on products Imprint Data Policy Whitepaper Site by Cookson Imprint Data Policy Whitepaper Site by Cookson Cookie Consent We use cookies to improve your experience on our site. By
Page not found - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Viewing by: It seems we can't find what you're looking for. X-Therma, Inc. North America 625 Alfred Nobel Drive Suite B Hercules, CA 94547 USA Europe X-Therma GmbH Langer Weg 11 6020 Innsbruck Austria [email protected] Request information on products Imprint Data Policy Whitepaper Site by Cookson Imprint Data Policy Whitepaper Site by Cookson Cookie Consent We use cookies to improve your experience on our site. By
Nanoscience With Antifreeze Proteins | X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Science We Need Better Cryoprotectants Lowering temperature is one of the most effective ways to slow cellular metabolism and extend storage times for biological materials. Storage at temperatures below 0°C is limited by the formation of ice crystals. Traditional cryoprotectants used to overcome this hurdle, such as dimethyl sulfoxide (DMSO), are limited in effectiveness and toxic to the very materials
Sponsored Symposia Skip to main content Home About Cell Transplant and Regenerative Medicine Society The Transplantation Society Committees Past Congresses Key Events in the History of the CTRMS Congress Venue Sustainable Initiatives Tours Tokyo Tourist Info & Free Tours Program Program Overview Detailed Program Call for Abstracts Poster Guidelines Audio Visual Guidelines Scientific Awards Keynote Speakers Plenary Speakers Networking and Young Investigator Events Registration & Hotel Registration Information Accommodation Sponsorship Confirmed Sponsors & Exhibitors Sponsorship Oppo … esting that align with the criteria that impact AM performance for the intended application. A case study will be presented that demonstrates how the biochemical characteristics of collagenase enzymes affected human islet yields, leading to fewer islet transplants being performed in 2007 as part of the Clinical Islet Transplantation Consortium clinical trial. Humanized Liver Chimeric Mice: A Versatile in Vivo Platform for Research on Liver Biology and Cell-Based Regenerative
X-Therma Achieves World’s First Subzero Organ Transports: Multiple 48-Hour Transatlantic Journeys Support First Steps Toward Tackling Organ Waitlist - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News X-Therma Achieves World’s First Subzero Organ Transports: Multiple 48-Hour Transatlantic Journeys Support First Steps Toward Tackling Organ Waitlist October 23, 2024 by Isaac Arruda Surgeons successfully transported pig kidneys between Baltimore and Innsbruck five times using X-Therma's F
Page not found - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Viewing by: It seems we can't find what you're looking for. X-Therma, Inc. North America 625 Alfred Nobel Drive Suite B Hercules, CA 94547 USA Europe X-Therma GmbH Langer Weg 11 6020 Innsbruck Austria [email protected] Request information on products Imprint Data Policy Whitepaper Site by Cookson Imprint Data Policy Whitepaper Site by Cookson Cookie Consent We use cookies to improve your experience on our site. By
Xiaoxi Wei, PhD - World Stem Cell Summit About WSCS About Us 2026 Regenerative Medicine Essentials Course Past WSCS Speakers WSCS Public Day (2023) Effective Patient Advocacy Symposium Intersection of RegMed & Healthspan Regenerative Medicine & the Commercial Space Economy Hot Topics in 2023 at World Stem Cell Summit Partners/Sponsors Partners/Sponsors Sponsorship Opportunities Upcoming Events News & Media News and Opinions WSCS 2023 Photos WSCS Video Contact Us Select Page Xiaoxi Wei, PhD Xiaoxi Wei, PhD Co-founder and CEO of X-Therma Inc. Xiaoxi Wei, Ph.D, is a co-founder and … CEO of X-Therma Inc. Xiaoxi Wei, Ph.D, is a co-founder and CEO of X-Therma Inc, award-winning entrepreneur and chemistry professional in the area of supramolecular assembly and biomimetic nanoscience. Dr. Wei is the inventor of X-Therma’s core technology based on hyper-effective ice prevention materials. She is also the lead author of eight peer-reviewed research papers and has been awarded 6 patents. Dr. Wei has served as Healthcare Advisor – UC Regents Working Group o
X-Therma Regenerative Medicine Solutions | X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us Preserving Life by Emulating Nature X-Therma pioneers a breakthrough biopreservation platform, transforming “living” medicines into on demand treatments. We empower patients with access to safe, reliable organs, engineered tissues, and advanced cell & gene therapies, dismantling the obstacles of time and distance. See Products > Products For Cell and Tissue Cryopreservation XT-Thrive ® cGMP g
X-Therma — Catalytic Impact Foundation 0 Skip to Content Home Who We Are About Us Team Foundation Advisors Ways to Give Impact Reports 2025 Impact Report 2024 Impact Report 2023 Impact Report Our Work Women's Health Initiative Children's Health Initiative Portfolio Portfolio Companies News & Events Portfolio Company News Press & Media Contact Fiscal Sponsorship Donate Open Menu Close Menu Home Who We Are About Us Team Foundation Advisors Ways to Give Impact Reports 2025 Impact Report 2024 Impact Report 2023 Impact Report Our Work Women's Health Initiative Children's Health Initia
Foundry Industry User X-Therma Raises Series A Funding for Biomimetic Peptoid Biopreservation Platform Skip to main content Skip to main content Skip to primary sidebar Skip to footer Molecular Foundry About Foundry Overview Industry @ the Foundry Strategic Priorities Scientific Facilities Strategic Plan Staff Scientific Advisory Board Careers Visit the Foundry Contact Expertise & Instrumentation User Program Overview Apply for Access Prepare to Work Working at the Foundry Project End & Reporting User Projects User Executive Committee Annual User Meeting Industry User FAQ User Progra … n Related instrumentation Biopolymers Footer Become a Foundry User Prepare Your Proposal User Portal Instrument Scheduler
X-Therma Showcases Groundbreaking Organ Preservation Technology at Johns Hopkins' "Hopkins on the Hill" Event | The Organ Donation and Transplantation Alliance Login Menu Learning Programs & Collaborative Events Advancement Series Tue, Jun 30, 2:00pm Innovations in Advanced Organ Preservation: Next-Gen Kidney Perfusion Tue, Aug 11, 2:00pm Electronic Referrals: The Good, The Bad and the Ugly Thu, Aug 13, 2:00pm Heart Transplant Innovation: Expanding What’s Possible Upcoming On-Demand Conversation Series Tue, Jul 28, 2:00pm Closing Gaps: Understanding Belief Systems Beyond W … Shift All Jobs Continuing Education Credits Many of our learning opportunities award continuing education credits for the healthcare community of practice. More Details 2026 40 Under 40 Nominations Learn More Resources & Insights Educational Guides Terminology & Data References DCD Educational Guide Community Hospital Resource Guide Transplant Resource Guide Insights The Quality Corner Hospital Executive Insights Transplant Executive Insights Spotlight One-Pagers Il … f good news. Please share yours. A great idea? An inspiring tale? A well-earned award? It’s OK to brag. We all could use good news. Would you like to nominate someone from your organization who goes above and beyond? We celebrate front line heroes. Please fill out our form to let us know. Click Here to Share Navigate Professional Development Resources Events News Insights About Us Publications Organ Donation Textbook Donation After Circulatory Death (DCD) Educational Guide Te
X-Therma Announces Oversubscribed Series A Financing - X-Therma Skip to content DMSO-Free Cryopreservation for MSC Banking: Read Publication Is It Time to Move Beyond DMSO? : Watch Webinar On-Demand Contact Us News X-Therma Announces Oversubscribed Series A Financing December 22, 2021 Arthi Shridhar RICHMOND, Calif. — December 22, 2021 — 6:00 AM PT — X-Therma Inc. , a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation – has closed an oversubscribed $13M Series A funding round. The financing is led by LOREA AG , an entrepreneur-operated inv … the Lawrence Berkeley National Laboratory and received over $11M contracts and grant support from the U.S. Department of Defense, the National Science Foundation, and the California Institute for Regenerative Medicine. The company recently closed an oversubscribed Series A of $13M. More News X-Therma Showcases Groundbreaking Organ Preservation Technology at Johns Hopkins’ “Hopkins on the Hill” Event Read More X-Therma Welcomes Biotech Veteran Neil Warma to